High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome

TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells

(2020) Elena Vendrame et al.   AIDS

NK cells for cancer immunotherapy

(2020) Noriko Shimasaki et al.   NATURE REVIEWS DRUG DISCOVERY

A New Hope for CD56negCD16pos NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases

(2020) Catherine S. Forconi et al.   Frontiers in Cellular and Infection Microbiology

CD56 regulates human NK cell cytotoxicity through Pyk2

(2020) Justin T Gunesch et al.   eLife

CD56-negative NK cells with impaired effector function expand in CMV and EBV co-infected healthy donors with age

(2019) Bojana Müller-Durovic et al.   Aging-US

CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse

(2019) Ghina Taouk et al.   Scientific Reports

A Natural Impact: NK Cells at the Intersection of Cancer and HIV Disease

(2019) Olivier Lucar et al.   Frontiers in Immunology

CD56 Expression Marks Human Group 2 Innate Lymphoid Cell Divergence from a Shared NK Cell and Group 3 Innate Lymphoid Cell Developmental Pathway

(2018) Luxi Chen et al.   IMMUNITY

B7-H6-mediated down-regulation of NKp30 in natural killer cells contributes to HIV-2 immune escape

(2018) Olivier Lucar et al.   AIDS

Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency

(2017) Yannick Simoni et al.   IMMUNITY

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival

(2017) Charlotte Viant et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types

(2017) Vincent van Unen et al.   Nature Communications

NKp30 expression is a prognostic immune biomarker for stratification of patients with intermediate-risk acute myeloid leukemia

(2017) Anne-Sophie Chretien et al.   Oncotarget

CD56 Is a Pathogen Recognition Receptor on Human Natural Killer Cells

(2017) Sabrina Ziegler et al.   Scientific Reports

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia

(2017) Anne-Sophie Chretien et al.   Frontiers in Immunology

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML

(2017) Anne-Sophie Chretien et al.   OncoImmunology

Wishbone identifies bifurcating developmental trajectories from single-cell data

(2016) Manu Setty et al.   NATURE BIOTECHNOLOGY

Human NK cell development requires CD56-mediated motility and formation of the developmental synapse

(2016) Emily M. Mace et al.   Nature Communications

Underground Adaptation to a Hostile Environment: Acute Myeloid Leukemia vs. Natural Killer Cells

(2016) Nicolas Dulphy et al.   Frontiers in Immunology

Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities

(2015) Anne Wanquet et al.   AMERICAN JOURNAL OF HEMATOLOGY

Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion

(2015) Zena Khaznadar et al.   JOURNAL OF IMMUNOLOGY

An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients

(2015) Jingling Zhou et al.   JOURNAL OF IMMUNOLOGY

Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia

(2015) Anne-Sophie Chretien et al.   Frontiers in Immunology

Prognostic significance of myelodysplasia-related changes according to the WHO classification among ELN-intermediate-risk AML patients

(2014) Raynier Devillier et al.   AMERICAN JOURNAL OF HEMATOLOGY

Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor Activity

(2014) Anne-Sophie Chretien et al.   Frontiers in Immunology

Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity

(2013) K. S. Reiners et al.   BLOOD

Innate or Adaptive Immunity? The Example of Natural Killer Cells

(2011) E. Vivier et al.   SCIENCE

Phenotypically and functionally distinct subsets contribute to the expansion of CD56−/CD16+ natural killer cells in HIV infection

(2010) Henoch S Hong et al.   AIDS

Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus

(2010) Niklas K. Björkström et al.   JOURNAL OF EXPERIMENTAL MEDICINE

CD56 negative NK cells: origin, function, and role in chronic viral disease

(2010) Niklas K. Björkström et al.   TRENDS IN IMMUNOLOGY

Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4

(2009) J. M. Milush et al.   BLOOD

The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia

(2009) E. Brunetta et al.   BLOOD

Expansion of Functionally Skewed CD56-Negative NK Cells in Chronic Hepatitis C Virus Infection: Correlation with Outcome of Pegylated IFN-  and Ribavirin Treatment

(2009) V. D. Gonzalez et al.   JOURNAL OF IMMUNOLOGY

Expansion of CD56− NK cells in chronic HCV/HIV-1 co-infection: Reversion by antiviral treatment with pegylated IFNα and ribavirin

(2008) Veronica D. Gonzalez et al.   CLINICAL IMMUNOLOGY